title: A phase II clinical trial of flutamide in the treatment of advanced breast cancer.
abstract: An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.
authors.affiliation: Medical Oncology Department, Shanghai Cancer Hospital, China.
authors.forename: T P
authors.initials: TP
authors.lastname: Zhao
authors.forename: G F
authors.initials: GF
authors.lastname: He
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D009325:Nausea / Q000139:chemically induced; D010865:Pilot Projects; D014839:Vomiting / Q000139:chemically induced
chemical_list: D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate